RHEI Pharmaceuticals Inc.
This article was originally published in Start Up
Executive Summary
Specialty pharma RHEI Pharmaceuticals' mission is to in-license China rights to partners' approved drugs or late-stage candidates, shepherd them through regulatory approval, and launch them in the China marketplace.
You may also be interested in...
Marinus Pharmaceuticals Inc.
Marinus Pharmaceuticals was founded to take ganaxolone, a problematic compound for which tantalizing human efficacy data already exists and reformulate it to overcome the pharmacokinetic and cost problems holding it back. In just two years since in-licensing it, Marinus has succeeded in reformulating the drug and putting it back into clinical testing for two epilepsy indications with hopes of building a multi-indication franchise around it.
Marinus Pharmaceuticals Inc.
Marinus Pharmaceuticals was founded to take ganaxolone, a problematic compound for which tantalizing human efficacy data already exists and reformulate it to overcome the pharmacokinetic and cost problems holding it back. In just two years since in-licensing it, Marinus has succeeded in reformulating the drug and putting it back into clinical testing for two epilepsy indications with hopes of building a multi-indication franchise around it.
Investing in India and China
Many life science venture firms are interested in opportunitites in China and India, but few have actually ponied up money.